Research Paper Volume 16, Issue 6 pp 5027—5037
Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress
Figure 1. Treatment with Phoenixin-20 (PHN-20) attenuated hypoxia-induced hemodynamics in rats. (A) Right ventricular systolic pressure (RVSP) (mmHg), (B) mean pulmonary arterial pressure (mPAP) (mmHg), and (C) right ventricle-to-left ventricle+septum (RV/LV + S) were measured (*, P<0.05 vs. control group; #, P<0.05 vs. hypoxia group).